Requires certain entities to stock opioid antagonists and to store naloxone nasal sprays with or adjacent to automated external defibrillator cabinets.
Summary
Bill A06014 mandates that various educational and public entities in New York, including school districts, public libraries, and charter schools, must stock opioid antagonists, specifically naloxone nasal sprays, on-site. This requirement aims to ensure that these entities can respond effectively to opioid overdoses, providing immediate access to life-saving medication for individuals experiencing such emergencies. The bill also stipulates that these opioid antagonists should be stored in proximity to automated external defibrillators, enhancing the preparedness of these facilities in emergency situations.
Furthermore, the bill requires that employees of these entities who are trained in administering opioid antagonists can do so during emergencies. The training must be conducted by approved programs, ensuring that staff members are adequately prepared to handle potential overdose incidents. Participation in this program is voluntary for individuals, but entities must comply with the broader requirements set forth in the public health law regarding opioid antagonist distribution and administration.
The legislation aims to bolster public health safety by integrating opioid overdose prevention measures within educational and public institutions. By requiring the stocking of naloxone and ensuring trained personnel are available, the bill seeks to reduce the incidence of fatal opioid overdoses, particularly among youth and community members who frequent these facilities.
The bill is set to take effect on July 1 following its passage, allowing time for the necessary implementation of rules and regulations. This timeline indicates a proactive approach to addressing the opioid crisis at the community level, particularly in environments frequented by young people and the general public.
Impact
If enacted, Bill A06014 will significantly alter the responsibilities of educational and public institutions in New York by mandating the stocking of opioid antagonists. This change will enhance the state's public health framework, particularly in combating the opioid crisis. The bill will also necessitate updates to existing health and safety protocols in schools and public libraries, ensuring that they are equipped to handle opioid overdose emergencies. Compliance with the new requirements will involve training staff and maintaining adequate supplies of naloxone, which may lead to increased operational costs for these entities.
Sentiment
The sentiment surrounding Bill A06014 appears to be largely supportive, as discussions emphasize the importance of addressing the opioid crisis and enhancing emergency preparedness in public spaces. Stakeholders recognize the necessity of having opioid antagonists readily available, particularly in environments where young people gather. However, there may be some concerns regarding the implementation logistics and the financial implications for schools and libraries tasked with maintaining these requirements.
Contention
Notable points of contention may arise regarding the financial burden placed on educational and public entities to comply with the new stocking and training requirements. Some critics may argue that the costs associated with purchasing naloxone and training staff could strain already limited budgets. Additionally, there may be discussions about the adequacy of training programs and whether they can effectively prepare staff to administer opioid antagonists in high-pressure situations.
Same As
Requires certain entities to stock opioid antagonists and to store naloxone nasal sprays with or adjacent to automated external defibrillator cabinets.
Requires certain entities to stock opioid antagonists and to store naloxone nasal sprays with or adjacent to automated external defibrillator cabinets.
Establishes a grant program to assist providers in purchasing opioid antagonists alongside automated external defibrillators; establishes criteria for such grant program.
Requires institutions of higher education to maintain supply of naloxone hydrochloride nasal spray for opioid overdose emergencies and permits emergency administration of naloxone hydrochloride nasal spray by licensed campus medical professionals and resident assistants.
Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.
Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.
Payment rates established for certain substance use disorder treatment services, and vendor eligibility recodified for payments from the behavioral health fund.
Cover Outstanding Vulnerable Expansion-eligible Residents Now Act or the COVER Now Act This bill establishes a demonstration program to allow local governments to provide health benefits to the Medicaid expansion population in states that have not expanded Medicaid. Under the program, local governments may provide coverage for individuals who are newly eligible for Medicaid under the Patient Protection and Affordable Care Act (i.e., the Medicaid expansion population) for a maximum of 10 years, or until their respective states expand Medicaid. The bill provides a 100% federal matching rate for the first three years of program participation. The bill prohibits states from taking certain actions against participating localities, such as withholding funding, increasing taxes, or restricting provider participation. States that violate these requirements are subject to certain funding penalties.